| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |